Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bile Acids and Sequestrants on GLP-1 After RYGB
NCT02952963Phase 4Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Oct 2016
- Primary completion
- Dec 2017
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chenodeoxycholic acid, colesevelam in obesity, sponsored by Copenhagen University Hospital - Hvidovre. Started Oct 2016; status: completed.
02
Drugs
chenodeoxycholic acidcolesevelam
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02952963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02952963.